What are the hallmarks of cancer?

Nature Reviews Cancer

Volumn 10, Issue 4, 2010, Pages 232-233

  Lazebnik, Yuri ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BENIGN TUMOR; CANCER INVASION; CANCER RESEARCH; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL; SOLID TUMOR; TUMOR GROWTH;

CELL CYCLE; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASMS; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 77950020483     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2827     Document Type: Note

References (23)

1. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
2. Giordano, A., De Falco, G., Rubin, E. & Rubin, R. in Rubin's Pathology: Clinicopathologic Foundations of Medicine (eds. Rubin, R. & Strayer, D. S.) (Wolters Kluwer, Lippincott Williams & Williams, Philadelphia, Baltimore, 2008).
3. Barnett, C. C. Jr et al. Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 128, 973-983 (2000).
4. Favia, G., Lumachi, F., Basso, S. & D'Amico, D. F. Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 128, 918-924 (2000).
5. Coleman, J. A. & Russo, P. Hereditary and familial kidney cancer. Curr. Opin. Urol. 19, 478-485 (2009).
6. Abouzeid, H., Schorderet, D. F., Balmer, A. & Munier, F. L. Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis. Mol. Vis. 15, 771-777 (2009).
7. Huntington, M. K., Kruger, R. & Ohrt, D. W. Large, complex, benign cystic teratoma in an adolescent. J. Am. Board Fam Pract 15, 164-167 (2002).
8. Udapudi, D. G., Vasudeva, P., Srikantiah, R. & Virupakshappa, E. Massive benign phyllodes tumor. Breast J. 11, 521 (2005).
9. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186 (1971).
10. Raica, M., Cimpean, A. M. & Ribatti, D. Angiogenesis in pre-malignant conditions. Eur. J. Cancer 45, 1924-1934 (2009).
11. Fleischer, R., Weston, G. C., Vollenhoven, B. J. & Rogers, P. A. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 603-614 (2008).
12. Lee, K. L. & Peehl, D. M. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J. Urol. 172, 1784-1791 (2004).
13. Utermark, T., Kaempchen, K., Antoniadis, G. & Hanemann, C. O. Reduced apoptosis rates in human schwannomas. Brain Pathol. 15, 17-22 (2005).
14. Okolo, S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 571-588 (2008).
15. Wanless, I. R. Benign liver tumors. Clin. Liver Dis. 6, 513-526 (2002).
16. Sozen, I. & Arici, A. Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors. Obstet. Gynecol. Clin. North Am. 33, 41-58 (2006).
17. Jagannathan, J., Oskouian, R. J., Yeoh, H. K., Saulle, D. & Dumont, A. S. Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base 18, 173-187 (2008).
18. Hansen, M. R., Roehm, P. C., Chatterjee, P. & Green, S. H. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53, 593-600 (2006).
19. Lucia, M. S. & Lambert, J. R. Growth factors in benign prostatic hyperplasia: basic science implications. Curr. Urol. Rep. 9, 272-278 (2008).
20. Henske, E. P. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosom. Cancer 38, 376-381 (2003).
21. Stoecklein, N. H. & Klein, C. A. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int. J. Cancer 126, 589-598 (2009).
22. Klein, C. A. Parallel progression of primary tumours and metastases. Nature Rev. Cancer 9, 302-312 (2009).
23. Jemal, A. et al. Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249 (2009).